№ lp_1_2_45867
File format: docx Character count: 22236 File size: 179 KB
Regulatory document establishing the legal, clinical and professional framework for community pharmacists in NHS Wales to supply fluconazole 150 mg for vulvovaginal candidiasis under a Patient Group Direction.
Year: 2023
Region: Wales
Country: United Kingdom
Healthcare system: NHS Wales
Document type: Patient Group Direction
Medicine: Fluconazole 150 mg capsule
Clinical indication: Vulvovaginal candidiasis
Service framework: Clinical Community Pharmacy Service
Service component: Common Ailment Service
Authoring body: Welsh Medicines Advice Service
Approving body: Community Pharmacy Clinical Advisory Group
Target professionals: Registered community pharmacists
Legal basis: Human Medicines Regulations 2012
Operational start date: 1 July 2023
Review date: 31 March 2026
Expiry date: 30 June 2026
Version: 1.0
Approval date: 3 July 2023
Source type: Regulatory and clinical governance document
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Patient Group Direction for Supply of Clotrimazole 1% Cream for Symptomatic Relief of Vulvo-Vaginal Candidiasis or Candidal Balanoposthitis (Version 2.0, July 2023)
Document type: Patient Group Direction (PGD) template
Medication: Clotrimazole 1% cream
Clinical indication: Vulvo-vaginal candidiasis; candidal balanoposthitis
Version: 2.0
Date of version update: July 2023
Template effective date: November 2023
Review date: May 2026
Expiry date: October 2026
Developing group: Sexual Health PGDs Short Life Working Group
Approving organisation: British Association for Sexual Health and HIV (BASHH)
Relevant guidance source: NICE MPG2 Patient Group Directions 2017
Sector: Sexual health services
Intended users: Registered healthcare professionals authorised to operate under a PGD
Organisational context: NHS or Local Authority commissioned sexual health services
Professional roles involved: Pharmacists, doctors, nurses, midwives, sexual health specialists
Governance requirement: Authorisation by senior doctor, senior pharmacist and organisational representative
Associated organisations: Specialist Pharmacy Service; Royal College of Midwives; Royal College of Nursing; Faculty of Sexual and Reproductive Healthcare; Centre for Pharmacy Postgraduate Education; British Pregnancy Advisory Service
Geographical scope: United Kingdom
Topics: Fluconazole Vulvovaginal Candidiasis